INTRODUCTION
It is well known that inflammation plays a key role in the pathogenesis of coronary artery disease. [1] [2] [3] The pathogenic role of T cells in atherosclerosis is well described in animal models. [4] [5] [6] [7] Recently, the association of pathogenic T cells with acute coronary syndrome in humans was addressed. [8] [9] [10] However, it remains unclear which specific subpopulation of T cells plays a major role in acute coronary syndrome. CD4
1 CD28 null T cells have been reported to contribute to acute coronary syndrome, 11, 12 and expansion of CD4 1 CD28 null T cells is strongly associated with the recurrence of acute coronary events. 11 Furthermore, in diabetic patients, an increased frequency of CD4 1 CD28 null T cells correlated with poor outcome after an acute coronary event. 12 However, a role for CD8 1 T cells in human coronary artery disease has been identified less than for CD4 1 T cells. 13 The accumulation of CD28 null T cells is one of the most prominent changes during the immune aging process.
14 Similarly, the expression of CD57, a terminally sulfated glycan carbohydrate epitope, on T cells is currently considered to be a surrogate marker of replicative senescence of T cells.
15 CD57 1 T cells fail to proliferate after antigen-specific stimulation in vitro and are highly vulnerable to activation-induced apoptosis. 16, 17 Furthermore, it was demonstrated that replicative senescence of T cells is better defined by the expression of CD57 than by a lack of CD28 expression, as determined by measurement of the T-cell receptor excision circle content and of the proliferative ability of T cells. 17 Notably, while CD57 1 T cells have been shown to be associated with various inflammatory diseases, [18] [19] [20] [21] [22] the pathogenic roles of CD57 1 T cells have yet to be elucidated in coronary artery disease. In the present study, we assessed the immunological characteristics of CD57 1 T cells, particularly CD8 1 CD57 1 T cells, in patients following acute myocardial infarction (MI) and analyzed their impact on clinical outcome.
MATERIALS AND METHODS

Study population
The present study included 58 prospectively and consecutively enrolled patients diagnosed with acute MI at the Severance Hospital from April 2010 to August 2010. Acute MI was defined as follows: (i) typical ischemic chest pain lasting for more than 30 min; ii) significant elevation of the ST segment or depression of two contiguous leads monitored by a standard 12-lead electrocardiogram; and iii) either elevation of the creatine kinase-MB isoform to greater than twice the normal upper limit or a rise in troponin T exceeding 0.1 ng/ml. Patients underwent a physical examination, electrocardiogram and laboratory examination at the time of initial enrollment. Whole blood was placed into an ACD anti-coagulated tube the morning after the patient was admitted to the hospital. Patients with a history of chronic inflammatory disease or who were taking anti-inflammatory medications were excluded from this study. The baseline characteristics of the study population are summarized in Table 1 . Informed consent was provided by all subjects, and the study was approved by the Institutional Review Board (Yonsei University College of Medicine).
Immunophenotyping analysis of peripheral blood mononuclear cells (PBMCs) PBMCs were isolated from whole blood using Ficoll-Hypaque (GE Healthcare, Uppsala, Sweden) and immediately analyzed for CD57 and CD28 expression. Any remaining PBMCs were cryopreserved and were later thawed and analyzed by flow cytometry. The cells were stained with fluorochromeconjugated monoclonal antibodies against surface antigens for 20 min at 4 uC. The antibodies used included anti-CD3-Horizon V500, anti-CD4-PE-Cy7, anti-CD8-APC-H7, anti-CD28-APC, anti-CD45RO-PerCP-Cy5.5, anti-CD56-PE, anti-CD62L-APC, anti-CD94-FITC, anti-CCR5-PE, anti-CCR7-PE, anti-PD-1-PE, anti-NKG2D-APC, anti-HLA-DR-FITC (all from BD Biosciences, San Jose, CA, USA), anti-CD57-eFluor 450, anti-FasL-PE (both from eBioscience, San Diego, CA, USA), anti-CX3CR1-FITC (MBL International, Woburn, MA, USA) and anti-CD127-APC (R&D Systems, Minneapolis, MN, USA). To access intracellular cytotoxic molecules, PBMCs were fixed and permeabilized using a Fixation/ Permeabilization Buffer Kit (eBioscience) and further stained for intracellular cytotoxic molecules with anti-perforin-PE, antigranzyme A-FITC and anti-granzyme B-APC (all from BD Biosciences). Multicolor flow cytometry was performed using an LSR II instrument (BD Biosciences), and FlowJo software (Treestar, San Carlos, CA, USA) was used to analyze the data.
In vitro stimulation of T cells and intracellular cytokine staining
PBMCs were stimulated with anti-CD3 antibody (100 ng/ml) for 6 hours. After 1 h of incubation, brefeldin A (GolgiPlug; BD Biosciences) and monensin (GolgiStop; BD Biosciences) were added to stimulate intracellular cytokine protein accumulation. Following surface staining with anti-CD3-horizon V500, anti-CD4-PE-Cy7, anti-CD8-APC-H7, anti-CD45RO-PerCP-Cy5.5 and anti-CD57-eFluor 450, the cells were fixed and permeabilized using the Fixation/Permeabilization Buffer Kit and further stained for intracellular cytokines with anti-TNF-a-FITC, anti-
IL-17A-PE and anti-IFN-c-APC (all from BD Biosciences).
To analyze the IL-12/IL-18-responsiveness of the T cells, PBMCs were cultured in the presence of IL-12 (20 ng/ml; Peprotech, USA) and IL-18 (100 ng/ml; Peprotech) for 48 h and then stained for the same surface markers and intracellular cytokines, with the exception of IL-17A. FACS analysis was performed using a LSR II flow cytometer (BD Biosciences), and the data were analyzed using FlowJo software (Treestar, San Carlos, CA, USA).
Statistical analysis
Continuous variables were reported as the means6s.d. Categorical variables were summarized by the percentage of the group total. Independent t-tests were used for continuous variables, and discrete variables were compared using the Chi-squared method. Intra-group comparisons were summarized using the paired t-test, and the Wilcoxon signed-rank test was used to verify the results. Multivariate logistic regression analysis was performed to identify independent predictors of cardiovascular mortality. The cumulative incidence of mortality was assessed with the Kaplan-Meier method. The statistical significance of the curves was calculated using the log-rank test. Statistical analyses were performed with SPSS 13.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
The relationship between the frequency of CD57
1 T cells and short-term cardiovascular mortality in acute MI patients During a 6-month follow-up period, seven (12%) events of cardiovascular mortality and three (5%) events of non-cardiovascular mortality occurred among the 58 subjects. First, we analyzed the frequency of CD57 1 or CD28 null T cells among the CD8 1 or CD4 1 T-cell subset present in the peripheral blood of the 48 patients who survived MI on the morning after admission to the hospital and compared the results to the seven cases of cardiovascular death. CD8
1 and CD4 1 T cells were identified in PBMCs by multicolor flow cytometry by gating single cells (forward scatter-area vs. forward scatter-height), lymphocytes (forward vs. side scatter) and staining for CD3, followed by staining for CD4 and CD8 (Figure 1a) . The frequency of CD57
1 cells (Figure 1b ; 45.6%67.0% vs. 23.3%615.7%, P50.001) or CD28 null cells (Figure 1c ; 42.3%66.9% vs. 24.3%617.7%, P50.011) in the CD8 1 T-cell subset was significantly higher in the group that suffered cardiovascular mortality. We also analyzed the CD4 1 T-cell subset. The frequency of CD57
1 cells in the CD4 1 T-cell subset was significantly higher in the cardiovascular mortality group (Figure 1d ; 5.6%64.5% vs. 3.0%63.0%, P50.047), while the frequency of CD28
null cells in the CD4 1 T-cell subset was not different between the two groups (Figure 1e ; 3.6%64.5% vs. 3.1%68.5%, P50.876). In multivariate analysis considering the age, gender and left ventricular ejection fraction (LVEF) of the patients, cardiovascular mortality was only associated with the frequency of CD57
1 cells in the CD8 1 T-cell subset (Table 2) ; thus, CD8
1
CD57
1 T cells were a focus of further analyses. In Figure 1f , representative flow cytometry plots are presented for CD57 and CD28 expression in the CD8 1 T-cell population. Although the CD57 1 cell population overlapped considerably with the CD28 null cell population (Figure 1f ), only the frequency of CD8
1
CD57
1 cells was independently associated with short-term cardiovascular mortality. Next, we divided the patients (48 cases of survival and seven cases of cardiovascular mortality) into two groups based upon the median percentage of CD8
1
CD57
1 T cells in the peripheral blood, and compared the survival between the two groups. The group with the higher frequency of CD8
1
CD57
1 cells (o25%) suffered a significantly greater rate of cardiovascular mortality than the group with the lower frequency of CD8
1
CD57
1 cells (P50.004) (Figure 1g ).
Immunophenotyping analysis of CD8
1 CD57 1 T cells from acute MI patients Because CD8
1 CD57 1 T cells were associated with poor prognosis following acute MI, we examined the immunophenotype of the CD8 1 CD57 1 T cells from acute MI patients. Compared with the CD8 1 CD57 2 T cells, the CD8 1 CD57 1 T cells expressed significantly higher levels of HLA-DR, PD-1 and FasL, which are all markers associated with the recent activation of T cells (Figure 2a ). CD8
1
CD57
1 T cells also showed a senescent and terminally differentiated phenotype, as determined by lower levels of CD28 and IL-7Ra expression and higher levels of CD45RO expression (Figure 2b ). Markers associated with natural killer cells, such as CD56, CD94 and NKG2D, were overexpressed on CD8 1 CD57 1 T cells compared with CD8 1 CD57 2 T cells (Figure 2c ). With respect to chemokine receptors, CD8
1 CD57 1 T cells expressed higher levels of tissue-homing markers (CX3CR1 and CCR5;
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HT Yu et al Figure 2d ) and lower levels of central-homing markers (CCR7 and CD62L; Figure 2e ) than CD8 1 CD57 2 T cells, suggesting that CD8
1 CD57 1 T cells are poised to migrate toward inflamed peripheral tissues. In summary, surface phenotyping analysis revealed that CD8 1 CD57 1 T cells are activated, senescent T cells with cytotoxic and tissue-homing properties.
Functional reactivity of CD8
1 CD57 1 T cells from acute MI patients We analyzed the functional characteristics of CD8 1 CD57 1 T cells from acute MI patients. First, we performed intracellular cytokine staining for IFN-c, TNF-a and IL-17A following anti-CD3 antibody treatment to mimic T-cell receptor (TCR) stimulation. In this regard, we found that while the frequency of IFN-c-or TNF-a-secreting cells in the CD8
1 CD57 1 T-cell population was significantly greater than that in the CD8 1 CD57 2 T-cell population, there was no difference in the frequency of IL-17A-secreting cells between the two populations (Figure 3a) . In addition, we examined IFN-c secretion by CD8 1 T cells in patients who survived (left) and patients who suffered from cardiovascular mortality (right). (g) The patients (48 cases of survival and seven cases of cardiovascular mortality) were divided into two groups by median level (25%) of CD57 1 T cell fraction in the CD8 1 T-cell population. Kaplan-Meier plot shows that the 6-month survival rate was significantly lower in patients with CD8
1 CD57 1 T cells o25% (dotted line) than in patients with CD8
1 CD57 1 T cells ,25% (solid line). *P,0.05. MI, myocardial infarction. Figure 3b ). These data suggest that the functional activation of CD8 1 CD57 1 T cells depends on TCR stimulation rather than IL-12/IL-18 stimulation. We also evaluated the cytotoxic capacity of CD8 1 CD57 1 T cells vs. CD8 1 CD57 2 T cells by intracellular staining of cytotoxic granule proteins such as granzyme A, granzyme B and perforin, and we found that these cytotoxic granule proteins were highly expressed by the CD8 1 CD57 1 Tcell population compared with the CD8 1 CD57 2 T cell population (Figure 3c ). Taken together, these data suggest that CD8 1 CD57 1 T cells might secrete IFN-c and TNF-a and exert higher cytotoxic function upon TCR engagement in vivo, and thus, they might participate in the pathophysiology of an acute coronary event.
DISCUSSION
In this study, we demonstrated that the frequency of CD57 1 cells in the CD8
1 T-cell population is associated with shortterm cardiovascular mortality in patients with acute MI. This is, to our knowledge, the first demonstration of a relationship between CD8
1 CD57 1 T cells and the clinical outcome of acute coronary syndrome. Immunophenotyping analysis revealed that CD8
1 CD57 1 T cells are activated, senescent T cells that have pro-inflammatory and high cytotoxic capacities and tissue-homing properties.
A role for senescent T cells in atherosclerotic diseases has been reported in several studies. 8, 9 Previous studies examining CD4 1 CD28 null T cells as a senescent T-cell population suggested a role in promoting vascular inflammation in atherosclerotic diseases, potentially contributing to plaque instability. 8 In fact, CD4
1
CD28
null T cells were demonstrated to accumulate in unstable plaques. 9 In this regard, CD4 
CD57
1 T cells hardly produced IL-17A upon anti-CD3 stimulation (Figure 3a) . Considering a recent report showing that IL-17 stabilizes atherosclerotic plaques through collagen production, 26 the inability of CD8
1
CD57
1 T cells to produce IL-17A might also associate with plaque instability in acute coronary syndrome.
Loss of CD28 expression is a well-known, senescent event of T cells, and CD28 null T cells accumulate with age. 27, 28 In addition, loss of CD28 expression is known to be associated with the expression of CD57, a terminally sulfated glycoprotein. 29, 30 Therefore, both the CD28 null and CD57 1 phenotypes of T cells have been considered markers of immunosenescence. 15 In fact, CD8
1 CD28 null T cells overlapped significantly with the CD8 1 CD57 1 T-cell population in our study ( Figure 1f) ; however, the short-term cardiovascular mortality of acute MI patients was independently associated with only the frequency of CD8
1 CD57 1 cells (Table 2 ). Current data suggests that the CD8 1 CD57 1 T-cell population is distinct from CD8 1 CD28 null T cells. Brenchley et al. 17 found that CD57 1 CD28 1 and CD57 2 CD28 null T cells both exist in the peripheral blood of HIV-seropositive patients. Moreover, it was shown that CD57 1 CD28 1 and CD57 1 CD28 null T cells undergo the same number of cell divisions and have shorter telomeres than CD57 2 T cells, which undergo fewer cell divisions than CD57 1 T cells, regardless of the CD28 expression. Together, these data indicate that CD57 expression better represents Tcell senescence than the loss of CD28 expression. In addition, the association between the frequency of CD8
1
CD57
1 T cells and cardiovascular mortality suggests that CD8 1 CD57 1 T cells might be functionally more relevant to the pathogenesis of acute coronary syndrome than CD8 1 CD28 null T cells. For these reasons, we focused on elucidating the functional capacity and antigen reactivity of CD8 1 CD57 1 T cells in acute MI patients. We also attempted to identify the stimuli that activate these senescent T cells and cause them to exert effector functions. Several studies have reported the relationship between the IL-12-and IL-18-mediated inflammatory responses and the pathophysiology and prognosis of atherosclerotic diseases. [31] [32] [33] 
2 T cells (Figure 3b ), while anti-CD3 antibody-induced IFN-c secretion was significantly higher from the CD8
1
CD57
1 T cell population (Figure 3a) . Recently, Hoffmann et al. 22 reported the immunophenotypic profiles of T-cell subsets in patients with acute MI following primary percutaneous coronary intervention. In that study, multiparameter flow cytometric analysis revealed that the frequency of CD4 
1 T cells before and after acute MI events must be analyzed in relation to cardiovascular mortality in the future. Second, the study population did not include healthy control subjects and thus, immunological characterization of T cells was conducted only in acute MI patients. A direct comparison of T-cell phenotype and function with age-and sex-matched healthy subjects would provide a more valuable immunological perspective for cardiovascular diseases. Third, the small size of the study population and the limited number of primary endpoints restricted a close analysis of the frequency of CD8 1 CD57 1 T cells as a prognostic factor in acute MI in the current study. In particular, we could not determine whether these CD8 1 CD57 1 T cells had an independent incremental value over other traditional factors of cardiovascular mortality in acute MI patients.
In summary, we identified a link between the frequency of CD8 1 CD57 1 T cells and short-term cardiovascular mortality in patients following acute MI. CD8
1 CD57 1 T cells have senescent, pro-inflammatory and high cytotoxic properties. This specific subset of T cells might contribute to plaque instability via high cytotoxic functions and pro-inflammatory cytokines, including IFN-c and TNF-a. Identification of a pathogenic CD8 1 T-cell subset expressing CD57 may offer new opportunities for the prevention and treatment of acute MI. 
1 T cells from acute MI patients. The MFI was compared for surface markers in both CD8
1 CD57 1 and their paired CD8 1 CD57 2 T cell populations (n558). Cells were stained with monoclonal antibodies against markers indicating the recent activation of T cells, such as HLA-DR, PD-1 and FasL (a), markers for the senescence and memory status of T cells, such as CD28, IL7Ra and CD45RO (b), natural killer cell-related proteins such as CD56, CD94 and NKG2D (c), tissue-homing markers such as CX3CR1 and CCR5 (d) and central-homing markers such as CCR7 and CD62L (e). The P value for each surface marker was calculated using the paired t-test. **P,0.01. MFI, mean fluorescent intensity; MI, myocardial infarction. 
2 T-cell populations was assessed by flow cytometry. The P value for each protein was calculated using the paired t-test. **P,0.01. MI, myocardial infarction; PBMC, peripheral blood mononuclear cell.
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